Master the essentials of key pricing and rebate concepts and methodologies

This intensive training program will give novices and experienced practitioners alike a thorough understanding of core pricing competencies and applicable changes in the reimbursement structures of key payor programs.

ACI’s goal is to provide you with a live glossary of essential pricing terminology, in addition to updates on the recent Proposed Rule and Executive Orders affecting drug pricing and reimbursement under the Medicaid and Medicare programs. We will provide a complete course of study for foundational elements, as well as a strategy guide for tackling complex challenges that will benefit the industry novice and the veteran.


Week 1
Nov. 1 & 3

Drug Pricing and Rebate Essentials and Introduction to Medicaid

Week 2
Nov. 8 & 10

Medicare Pricing and Rebate Essentials and Advanced CMS Pricing and Rebate Topics

Week 3
Nov. 15 & 17

PHS 340 B, VA and DoD Rx Pricing and Rebates

Week 4
Nov. 29 & Dec. 1

Pricing and Reimbursement for New Products and Therapies

EXPERT INSTRUCTORS

Learn from a Renowned Faculty of Masters in Rx Drug Pricing and Rebates:

Keren Tenenbaum

Keren Tenenbaum

VP and Assistant General Counsel, Head of Legal, Salix
Bausch Health Companies Inc.

Margaux Hall

Margaux Hall

Partner
Ropes and Gray LLP

Joy Sturm

Joy Sturm

Partner
Hogan Lovells LLP

Trevor Wear

Trevor Wear

Partner
Sidley Austin LLP

Merle DeLancey

Merle DeLancey

Partner
Blank Rome LLP

T. Reed Stephens

T. Reed Stephens

Partner
Winston & Strawn LLP

REAL-LIFE BENEFITS OF ATTENDING

UNDERSTAND how price is established and how the rebate system works

DEFINE key pricing terms under Medicaid, Medicare, PHS 340 and other key government payor programs

MAKE sense of complex pricing and rebate calculations that go beyond the essentials

EXAMINE the latest developments impacting the drug pricing and rebate programs, from the CMS final rule on MDRP and 340b litigation to the most favored nation model and more…

COMPREHEND pricing strategies and key considerations for new products and therapies

WHO SHOULD ATTEND
LAW FIRMS
  • Attorneys with practice areas in:
    • Government Contracts and Managed Markets
    • Pharmaceuticals
    • Healthcare
    • Food & Drug
PHARMACIES
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing
    • Business Development
GOVERNMENT AFFAIRS
  • Financial Analysts
PHARMACEUTICAL COMPANIES
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pricing, Pricing Strategy, Pricing Analytics
    • Contracts and Reimbursement
    • Managed Markets
    • Managed Care
    • Government Programs
    • Medicaid/Medicare Rebates
    • Finance/Accounting/Audit
    • Government Affairs
  • Compliance Officers
PBMs
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Contract Management
    • Network Pharmacy
    • Retail Pharmacy Operations
    • Government Programs
    • Pricing and Operations
    • Clinical Operations
    • Industry Relations
PLANS
  • Corporate Counsel/General Counsel
  • Vice Presidents, Officers, Directors and Managers for:
    • Pharmacy Networks
    • Pharmaceutical Contracting
    • Clinical
    • Pharmacy Services
TESTIMONIALS
Quote Icon

Excellent and very capable list of speakers. Not always this good and comprehensive at other programs.

VP, Us Commercial Legal Lundbeck LLC
Quote Icon

All encompassing overview of government program and current issues.

Director of Pricing and Contracts, Horizon Pharmaceuticals
Related Conference